Partnership aims to enhance kidney care through clinician training
AstraZeneca India has joined forces with the Indian Society of Nephrology (ISN) to establish the Chronic Kidney Disease Academy. This collaborative initiative aims to provide clinicians with module-based learning to enhance their ability to deliver comprehensive kidney care to patients. The academy’s training program will cover the pathophysiology, diagnosis, complications, and management of chronic kidney disease (CKD).
Strengthening efforts for early detection and holistic management of CKD
The partnership between AstraZeneca and ISN was announced on World Kidney Day, underscoring their commitment to generating awareness and educating the public about ways to improve kidney health. The objective is to create a nationwide impact by emphasizing the importance of early diagnosis, prompt management, and holistic care for CKD. By addressing the burden of CKD, the collaboration aims to reduce adverse outcomes and alleviate the economic burden on individuals and healthcare systems.
CKD prevalence and the need for enhanced care in India
According to a study conducted by the Indian Society of Nephrology, approximately one in every ten adults in India suffers from CKD at any given point. Surprisingly, it was found that about 20% of patients with CKD are aged 38 years or younger. This highlights the need for early identification and prognosis of CKD to delay disease progression and improve outcomes. Furthermore, it is estimated that a significant proportion of patients remain undiagnosed, necessitating increased efforts to raise awareness and promote screening initiatives.
Empowering clinicians and prioritizing kidney health
The Chronic Kidney Disease Academy is a collaborative effort to equip clinicians and healthcare practitioners with the knowledge and skills needed to provide comprehensive kidney care. By adhering to the theme of “Kidney Health For All” set by World Kidney Day, AstraZeneca and ISN aim to create a significant impact in improving kidney health and reducing the burden of CKD. The involvement of top nephrologists as faculty members ensures the dissemination of accurate health information and the enhancement of clinical outcomes for patients.
AstraZeneca India has partnered with the Indian Society of Nephrology to launch the Chronic Kidney Disease Academy, offering module-based learning for clinicians to improve kidney care. The program aims to raise awareness, provide early diagnosis, and promote holistic management of CKD. With one in ten adults in India affected by CKD, this initiative seeks to empower healthcare practitioners and prioritize kidney health. Read more about this collaboration and its impact on public health.